P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy

BACKGROUND: Evaluating the degree of protection afforded to multiple myeloma (MM) patients by vaccination against SARS-CoV-2 is of critical importance due to the high morbidity and mortality associated with infection and the immunosuppression associated with MM and its treatment. We have previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Bird, Sarah, Panopoulou, Aikaterini, Shea, Robyn, Tsui, Micky, Saso, Radovan, Sud, Amit, West, Sharon, Smith, Katy, Barwood, John, Kaczmarek, Ewa, Panlaqui, Carmela, Kaiser, Martin, Stern, Simon, Boyd, Kevin, Pawlyn, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580189/
http://dx.doi.org/10.1016/S2152-2650(21)02271-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580189/
http://dx.doi.org/10.1016/S2152-2650(21)02271-0

Ejemplares similares